Jardiance Tablets 25 Mg - Empagliflozin For Type 2 Diabetes

Jardiance Tablets 25 Mg - Empagliflozin For Type 2 Diabetes & Heart Failure

Jardiance Tablets, containing 25 mg of Empagliflozin, are designed to improve blood sugar levels in individuals with type 2 diabetes and reduce the risk of cardiovascular death in adults with cardiovascular disease. As a sodium-glucose co-transporter 2 (SGLT2) inhibitor, Jardiance works by blocking the SGLT2 protein in the kidneys, preventing sugar and sodium from being reabsorbed into the body. This mechanism helps lower blood sugar levels and reduces stress on the heart and kidneys.

• Improves blood sugar control in type 2 diabetes
• Reduces risk of cardiovascular death
• Effective in combination with other diabetes medications

• Active Ingredient Empagliflozin
• Strength 25 mg
• Dosage Form Tablet

Jardiance is used for managing type 2 diabetes and reducing cardiovascular risks. It is suitable for adults with heart failure and chronic kidney disease.

Boehringer Ingelheim, the manufacturer of Jardiance, is a leader in pharmaceutical innovation, particularly in the field of diabetes management. Their commitment to research and development has positioned them as a trusted authority in healthcare solutions.